Cooke Vesselina G, Kalluri Raghu
Division of Matrix Biology, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, USA.
Methods Enzymol. 2008;444:1-19. doi: 10.1016/S0076-6879(08)02801-2.
Angiogenesis, the process of new blood vessel formation, is regulated on both genetic and molecular levels. Pro- and anti-angiogenic stimuli maintain the angiogenic balance, and the tipping of that balance toward pro-angiogenic activity is critical for tumor growth and survival. Endogenous inhibitors of angiogenesis, many of which are fragments from large extracellular matrix proteins, counter the effect of growth factors and keep angiogenesis in check. This chapter will discuss the molecular mechanisms of endogenous inhibitors derived from type IV collagen and review the in vitro and in vivo assays available to study their role in angiogenesis.
血管生成,即新血管形成的过程,在基因和分子水平上均受到调控。促血管生成和抗血管生成刺激维持着血管生成的平衡,而这种平衡向促血管生成活性的倾斜对于肿瘤的生长和存活至关重要。血管生成的内源性抑制剂,其中许多是大型细胞外基质蛋白的片段,可对抗生长因子的作用并控制血管生成。本章将讨论源自IV型胶原的内源性抑制剂的分子机制,并综述可用于研究其在血管生成中作用的体外和体内试验。